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Abstract
Purpose In its typical form and when seen at onset,
Vogt-Koyanagi-Harada (VKH) is characterized by
easily recognizable signs that allow diagnosis without
difficulty. In cases that do not have acute onset, that
are seen at a later stage or that do not show the
complete set of signs, appraisal is more difficult and
diagnosis may cause difficulties. We present here a
case of bilateral granulomatous uveitis compatible
with VKH disease in order to allow several experts to
give their opinion on the most appropriate manner to
confirm or reject the diagnosis and their approach to
the management of the case.
Case presentation A 17-year-old female patient
consulted her ophthalmologist for blurred vision
OU following an episode of a flu-like disease with
malaise, fever and headaches. A bilateral anterior
granulomatous uveitis with a right papillitis was
diagnosed and the patient presented with a bilateral
acute myopization. Fluorescein angiography showed
right disc hyperfluorescence with late leakage and
slight left disc hyperfluorescence. The patient was
given a course of one week of peroral corticosteroid
therapy followed by an intramuscular injection of
Bentelan1 twice weekly. In the absence of significant
improvement the patient was sent six weeks later to a
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specialized center where a complete work-up was
performed.
Expert opinion The diagnostic work-up, investiga-
tional tests, and differential diagnosis to confirm or
reject the diagnosis of VKH as well as the manage-
ment of the case will be described by the experts.
Keywords Bilateral anterior granulomatous
uveitis  Papillitis  Acute myopization
Introduction
Vogt-Koyanagi-Harada disease, when presenting in its
typical clinical expression and when ocurring in a
geographic area where the disease is prevalent, is a
well-characterized disease not causing major diagnos-
tic problems either because it is sufficiently typical or
because clinicians are used to diagnose it [1]. Diag-
nostic criteria were defined back in 1980 but are
difficult to use as they mix signs and symptoms of
acute and chronic disease that do not usually coexist
[2]. To diagnose acute VKH disease bilateral exuda-
tive retinal detachments without any known history of
ocular trauma are needed following these diagnostic
criteria. In 2001 the first workshop on VKH at Lake
Arrowhead, California published revised diagnostic
criteria for VKH that distinguish between acute and
chronic signs and are useful for reporting cases in
studies but are still unsatisfactory for practical use as
they do not include new, more-sensitive diagnostic
modalities such as indocyanine green angiography [3].
In cases of suspected VKH disease that do not have
acute onset, that are seen at a later stage or that do not
show the complete set of signs, diagnosis of VKH
becomes more difficult. In atypical cases clinicians
should use all possible diagnostic means to reach a
diagnosis without delay, as early and appropriate
therapy is essential for this disease [4]. Another reason
to use more invasive diagnostic modalities to reach a
high probability of correct diagnosis is that the
proposed therapy will be heavy and prolonged.
Case report
A 17-year-old female patient consulted her ophthal-
mologist for blurred vision OU following an episode of
a flu-like disease with malaise, fever and headaches. A
bilateral granulomatous anterior uveitis with a right
papillitis was diagnosed and the patient presented
bilateral acute myopization. The patient was given a
course of one week of peroral corticosteroid followed
by intramuscular injections of Bentelan1 (betameth-
asone sodium bi-phosphate 4 mg) twice a week. In the
absence of significant improvement the patient was
sent six weeks later to the ophthalmology unit of the
Ospedale Valduce in Como, Italy and the patient was
also seen in the Center for Inflammatory Eye Diseases,
Centre for Ophthalmic Specialized Care, La Source,
Lausanne, Switzerland. When the patient was seen, she
had been again under peroral prednisone (50 mg/day)
for one week and systemic Aulin1 (nimesulfide), a
nonsteroidal anti-inflammatory agent. Locally the
therapy consisted of dexamethasone phosphate 0.1%
drops QID and dilating drops. Visual acuity on the right
was 0.2 without correction, improving to 0.9 with a
correction of sph. 2.25. Visual acuity on the left was
0.1 without correction, improving to 0.6 with a
correction of sph. 2.5. There were granulomatous
keratitic precipitates (KPs) on the endothelium on both
sides. The anterior chamber showed a 2+ flare OU and
1+ cells in the anterior chamber. Laser flare photom-
etry showed appreciable inflammation with values of
49.2 ph/ms OD and 84.6 ph/ms OS. Intraocular
pressure was 6–7 mmHg OU. There was a vitreous
cellular infiltration of 2+ OU. Examination of the
fundus showed disc swelling OD and the maculas were
radially wrinkled OU (Fig. 1). The visual fields showed
Fig. 1 Red-free photograph of the posterior pole of the right
eye showing disc swelling
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relative scotomas and a decrease of the mean sensitiv-
ity OU (Fig. 2). Fluorescein angiography showed right
disc hyperfluorescence with massive late exudation
and slight left disc hyperfluorescence (Fig. 3a, b).
Optical coherence tomography performed with the
scanning laser ophthalmoscope-optical coherence
tomography (SLO/OCT) system produced by Oph-
thalmic Technologies (OTI, Toronto, Canada) clearly
showed the wrinkles of the retina-vitreous interface on
the coronal C-scans as well as a probable fine layer of
subretinal fluid OU (Fig. 4a, b). Ultrasound biomi-
croscopy (UBM) examination of the ciliary body
showed supraciliary effusion, explaining the myopiza-
tion noted since the beginning of the inflammatory
episode (Fig. 5a, b).
In summary, this 17-year-old girl presented a
bilateral granulomatous anterior uveitis with supra-
ciliary effusions OU, bilateral vitritis, prominent right
papillitis and slight left papillitis resistent to a
systemic dose of 50 mg of prednisone per day. A
complete re-evaluation of the situation was decided.
At this point expert opinion is solicited on the
diagnostic work-up, investigational tests, differential
diagnosis to confirm or invalidate the potential
diagnosis of VKH as well as on the management of
the case.
Expert opinions
1. Ahmed Abu El Asrar (Saudi Arabia)
A 17-year-old female who presented with blurred
vision of both eyes following an episode of flu-like
disease, bilateral granulomatous anterior uveitis,
vitreous cells, optic nerve head swelling and retinal
folds in the macular area (Fig. 1). Fluorescein
angiography showed optic nerve head early leakage
and late staining in both eyes, which was more
intense in the right eye and multiple pinpoint areas of
leaks in the peripapillary area in the right eye (Fig. 3).
Optical coherence tomography revealed very shallow
bilateral exudative retinal detachment (Fig. 4). Ultra-
sound biomicroscopy examination showed supracil-
iary body effusion (Fig. 5).
Vogt-Koyanagi-Harada disease should be consid-
ered. The hallmark of active uveitis in Vogt-Koyan-
agi-Harada disease is bilateral exudative retinal
detachments associated with hyperemia and edema
of the optic nerve head. The patient’s ethnic back-
ground is important, as Asians, Native Americans,
Hispanics, Asian Indians and Middle Easterners are
affected most frequently [1]. The patient should be
questioned and examined carefully for the presence
of poliosis of the eyebrows, eyelashes, and scalp hair,
alopecia, and vitiligo. She should also be asked about
hearing loss. At this point, I would suggest routine
laboratory studies including complete blood cell
count, erythrocyte sedimentation rate, chest X-ray,
venereal disease research laboratory test, fluorescent
treponemal antibody absorption test, blood chemistry,
urinalysis, and tuberculin skin testing. In addition, I
would do indocyanine green angiography, and ultra-
sonography, and order full audiologic assessment. In
an active disease, ultrasonography shows diffuse
thickening of the choroids [2]. Indocyanine green
angiography is useful in delineating the pattern of
choroidal involvement and to monitor the effect of
Fig. 2 Computerized visual
fields performed with the
Octopus1 instrument,
showing decrease of mean
sensitivity and relative
scotomata bilaterally
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treatment [5, 6].1 In our patients with Vogt-Koyan-
agi-Harada disease, sensory hearing loss was docu-
mented in about 50% of patients after full audiologic
assessment including pure-tone audiogram, tympan-
ogram, auditory brain-stem response, autoacoustic
emission, and caloric test [3]. In our setting, lumbar
puncture is rarely necessary as history, clinical
examination, ultrasonography, and fluorescein angi-
ography are usually sufficient to establish the diag-
nosis of Vogt-Koyanagi-Harada disease. However,
lumbar puncture is a useful adjunctive test in cases of
atypical Vogt-Koyanagi-Harada disease to confirm
the diagnosis.
Early and aggressive high-dose systemic cortico-
steroid therapy has become the mainstay of therapy in
Vogt-Koyanagi-Harada disease [4, 5]. It is clear that
this patient was not adequately treated with corticos-
teroids. I would recommend treatment with intrave-
nous methylprednisolone 1 g daily for three days
followed by oral prednisone 1 mg/kg/day with slow
tapering over 9–12 months depending on the clinical
response. Our study identified a significant associa-
tion between final visual acuity of 20/20 and use of
systemic corticosteroid therapy for longer than
nine months. In addition, we demonstrated a signif-
icant association between rapid tapering of systemic
corticosteroid therapy and worse final visual acuity,
and recurrent episodes of inflammation [3].
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Clinical features of this patient are compatible with
Vogt-Koyanagi-Harada (VKH) disease although ocu-
lar signs of the patient are atypical for VKH disease.
It is known that some proportion of VKH disease
Fig. 4 (a) Optical
cohererence tomography
(OCT): coronal C-scan
performed with the OTI
SLO/OCT optical
coherence tomograph in the
right eye, showing the
wrinkled surface of the
retina. (b) OCT: sagittal B-
scan-mode section
performed with the OTI
SLO/OCT optical
coherence tomograph in the
right eye, showing a
hyporeflective layer
between retina and retinal
pigment epithelium,
indicating subretinal fluid
not seen on fluorescein
angiography
Fig. 5 (a) Ultrasound biomicroscopy (UBM) showing supra-
ciliary effusion on a radial scan. (b) UBM: scan parallel to the
limbus at the level of the ciliary body situated slightly posterior
to the pars plicata, showing supraciliary fluid
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sufferers exhibit bilateral papillitis with minimal
exudative retinal detachment; this is classified as
papillitis-type VKH disease in Japan. Acute myop-
ization accompanied by a shallow anterior chamber at
the active stage of VKH disease has been previously
reported [1, 2] and is a common ocular manifestation
of the disease in Japan. Ultrasound biomicroscopy
(UBM) is useful for the assessment of anterior
chamber depth and exudative detachment of the
ciliary body [3, 4], which can cause shallow anterior
chamber and acute myopization.
Considering bilateral granulomatous anterior
uveitis concomitant with papillitis, sarcoidosis,
multiple sclerosis and chronic idiopathic anterior
uveitis in young girls might be listed as differential
diagnosis. Required investigational tests in this
patient are serum ACE, serum lysozyme and chest
X-ray for sarcoidosis. Cerebrospinal fluid (CSF)
examination and magnetic resonance imaging
(MRI) examination of the central nervous system
and an audiogram should be done to differentiate
VKH disease and multiple sclerosis. CSF examina-
tion in patients with VKH disease shows pleocy-
tosis with mononuclear cells and/or melanin-laden
macrophages [5].
As for ophthalmic examinations, indocyanine
green angiography (ICGA) should be done to exam-
ine whether the choroidal inflammatory lesions are
present, despite the fact that ophthalmoscopic exam-
ination and fluorescein angiography revealed minimal
changes in the ocular fundus. In the acute stage of
VKH disease, ICGA demonstrates filling delay of
choroidal vessels at early phase, followed by multiple
dark spots in the choroid at late phase (Figure).
Multiple dark spots at late phase are considered to
reflect the granulomatous choroidal lesions. These
ICGA findings can be used as signs of active
choroidal inflammation.
Because moderate dosage of systemic corticoste-
roid was not sufficient in this patient, intensive
treatment is recommended, such as steroid pulse
therapy (1,000 mg of methylprednisolone for
three days), followed by a daily dosage of 1 mg/kg
for one week at least, and slow dose reduction for 6–
8 months. Of course, careful assessments for the
inflammatory activities, including ICGA, UBM and
OCT, should be performed during the treatment, in
addition to assessment for general adverse events of
systemic corticosteroid.
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This case highlights the not infrequent phenomenon
of transient myopic shift in patients with acute onset
panuveitis, particularly seen in VHK disease. The
Indocyanine green angiography in a Japanese patient with
VKH disease. Multiple dark spots in the choroid were seen at
the intermediate phase (12 min)
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myopic shift is presumably due to acute ciliary-body
inflammation and secondary swelling or even accu-
mulation of subciliary body fluid (supraciliary effu-
sion), resulting in anterior movement of the lens
diaphragm. Ultrasound biomicroscopy of the ciliary
body is diagnostic of this condition. Ciliary body
swelling and/or subciliary body fluid may also
occasionally be observed in eyes immediately after
pars plana vitrectomy (ref. a), presumably due to
postoperative inflammation.
This case is also characterized by difficulty in
obtaining a diagnosis. The clinical features of VKH
disease may often appear atypical if the patient
presents late in the course of disease or receives
inadequate treatment early on. The typical finding of
acute bilateral serous retinal detachments in VKH
disease will subside without treatment, however
chronic and/or recurrent granulomatous inflammation
often ensues in these cases with various complica-
tions resulting. The avoidance of ocular complica-
tions such as cataract, glaucoma, chorioretinal
atrophy, subretinal fibrosis, choroidal neovascular-
ization and retinal detachment is the primary reason
for using prompt and aggressive systemic therapy in
acute VKH disease. The diagnosis is often aided by
lumbar puncture, which may reveal pleocytosis in up
to 80% of Japanese patients (ref. b) and may persist
for as long as eight weeks (ref. c). Furthermore,
thorough questioning of this particular patient may
have revealed ciliary-pattern bulbar conjunctival
injection in the early stages coincident with her flu-
like symptoms. Despite not being included in the
current international VKH disease diagnostic criteria
(ref. d), transient bilateral ciliary injection in the
absence of discharge is a frequent early manifestation
and would increase one’s clinical suspicion. Of
course, it may be helpful to note the patient’s
ethnicity, since VKH disease occurs much more
frequently in individuals with mongoloid heritage
such as Asians, American Eskimos, American Indi-
ans and certain Hispanic groups.
Since the patient in this case report had character-
istic systemic symptoms early in the course of the
disease and presented with bilateral granulomatous
panuveitis, VKH disease would be high on the list of
differential diagnoses. As mentioned above, a lumbar
puncture even a few weeks after the onset of
symptoms may still have been positive and would
have supported aggressive therapy. The ethnicity of
the patient was not stated, however I would consider
checking for the HLA-DR4 phenotype, present in up
to 93% of VKH disease patients in some areas of the
world (ref. e). Finally, given a young healthy adult
with presumably no contraindications, studies have
shown good visual outcomes with aggressive initial
systemic corticosteroid therapy (ref. f). This patient
responded inadequately to oral prednisone at a dose
of roughly 1 mg/kg/day with persistent and quite
active papillitis in both eyes. Therefore I would
consider pulse doses (1,000 mg/day) of methylpred-
nisolone given intravenously for three days followed
by continuation of oral corticosteroids tapered over
6–12 months, depending on the clinical response to
the pulse therapy. In a young healthy adult, steroid-
sparing agents will probably not be necessary as long
as posterior pole recurrences are not observed. If the
latter occur, steroid-sparing agents should be consid-
ered early on, since a longer course of systemic
treatment will likely be necessary.
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The present case presents a diagnostic challenge
since it reveals few clinical features in favor of
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diagnosis of VKH disease and others that are against
such a diagnosis. The patient’s prodromal symptoms
support the diagnosis of VKH disease, but it is
unusual for this disease to present with signs of
granulomatous anterior uveitis (AGU) at such an
early phase. This AGU typically appears during the
chronic or chronic recurrent phases of the disease.
Moreover the asymmetric optic disc changes and the
fluorescein angiographic findings do not favor a
diagnosis of VKH disease. Since several of the
clinical findings are atypical for VKH, it is essential
that the patient undergo additional investigation to
rule out other causes of granulomutous panuveitis
associated with optic disc changes such, as sarcoid-
osis, tuberculosis, syphilis or cat scratch disease. In
addition to obtaining an in-depth medical history and
a systemic review, laboratory investigations such as
angiotensin converting enzyme levels, serology for
syphilis, PPD, chest X-ray and anti-B henselae
antibodies will be required to establish the diagnosis.
Although evaluation of cerebrospinal fluid (CSF)
for pleocytosis can be helpful in the diagnosis of
VKH disease, in the present case, the CSF may be
negative. In about 20% of patients with VKH, lumbar
puncture results are found to be negative [1].
Moreover, about 88% of patients with sarcoidosis
involving the optic nerve may show lymphocytic
pleocytosis and/or elevated protein in the CSF [2].
Thus a lumbar puncture may not unequivocally
confirm the diagnosis of VKH disease in the present
case. Since (HLA) DRB1 0405 is strongly associated
with VKH disease, detection of such class II mole-
cules may aid in the diagnosis of VKH disease [3].
Since none of the above investigations can provide
a definitive diagnosis or rule out VKH disease, a
noninvasive ultrasound examination of the retina-
choroid should be undertaken. This procedure can
either support the diagnosis of VKH or refute the
possibility. Since the patient exhibits granulomotous
panuveitis, if an ultrasound finding of diffuse cho-
roidal thickening, more prominent in the juxtapapil-
lary area with a gradual reduction in thickness toward
the equator and anterior choroid would support a
diagnosis of VKH disease [4]. Such choroidal
thickening is typically seen in both VKH and
sympathetic ophthalmia. Since there is no history of
penetrating ocular injury in the present case, the
above findings, if noted, could support the diagnosis
of VKH disease. In contrast, should the choroid
reveal thickening without the above unique features,
a diagnosis of sarcoidosis or another granulomatous
uveitis entity should be entertained. In addition to
ultrasonography, indocyanine green angiography may
prove useful in arriving at the diagnosis.
In summary, further investigation is required to
arrive at a definitive diagnosis. The ultrasound
examination, along with the described investigation,
may either support or refute the diagnosis of VKH
disease and pave the way for establishing a proper
diagnosis.
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Actual management of case
Indocynine green angiography was performed, show-
ing evenly distributed and evenly sized bilateral
hypofluorescent dark dots, indicating the widespread
choroidal stromal granulomas typically seen in VKH
disease (Fig. 6a, b). With this information it was
decided to perform a lumbar puncture that showed 80
lymphocytic cells per mm3, confirming the diagnosis
of VKH disease. A therapy consisting of an infusion
of 500 mg of methylprednisolone per day during
three days was decided followed by peroral predni-
sone (1.5 mg/kg) and the introduction of azathioprine
(2.8 mg/kg) was decided. Three days later ICGA
showed clear regression of the hypofluorescent dark
dots in the posterior pole (Fig. 7a) when compared to
the situation 4 days earlier before the administration
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of intravenous methylprednisolone (Fig. 7b), giving
further credit to the diagnosis of VKH disease. Visual
acuity increased to 1.0 (OD) and 0.9 (OS) with a
bilateral spherical best correction that decreased to
0.75 diopters. Wide-angle ICGA however showed
persistance of hypofluorescent dark dots in the
periphery (Fig. 8).
Discussion
This is a case of VKH disease that presented
atypically because the inflammatory involvement
was anterior at the very onset of disease with only
a unilateral posterior involvement not including
clinical and angiographic serous retinal detachments.
One of the reasons that the case still presented
atypically six weeks later when seen in a specialized
center was that the administration of systemic
corticosteroid therapy, even though given at an
insufficient dosage and for too short a course, masked
the full expression of the disease. In the case of
atypical clinical presentation and suspicion of VKH
disease, clinicians should not hesitate to use all
diagnostic modalities at their disposal to compensate
for the absent clinical signs. One of the new
diagnostic modalities that has substantially refined
our capacity to diagnose VKH disease, especially in
asymmetric or clinically unilateral cases or with a
reduced degree of severity, is indocyanine green
angiography (ICGA) [5–9]. ICG angiography here
gave the most useful information, typically showing
the numerous evenly distributed hypofluorescent dark
dots in the choroidal stroma, indicating the presence
of choroidal stromal granulomata. These essential
ICGA findings in turn strengthened the probability of
the diagnosis of VKH disease justifying the more-
invasive lumbar puncture that finally unmistakenly
confirmed the diagnosis. The certainty of the diag-
nosis justified the administration of very high-dose
intravenous corticosteroids and the immediate intro-
duction of an immunosuppressive agent. A further
utility of ICGA was to monitor the significant
decrease of the hypofluorescent dark dots after
Fig. 6 (a) Indocyanine green angiography (ICGA) OD:
numerous evenly sized and evenly distributed hypofluorescent
dark dots indicating stromal granulomata in the right eye. (b)
ICGA OS: numerous hypofluorescent dark dots indicating
stromal granulomata in the left minimally inflamed eye
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three days of megadose intravenous corticosteroids.
Interesting but less-specific information was given by
OCT, which showed wrinkling of the retinal surface
especially well shown with the instrument manufac-
tured by Ophthalmic Technologies that allows
coronal scanning (C-sections) cutting through the
posterior pole. The classical longitudinal/sagittal
(B-scan-mode) sections showed subretinal liquid that
was not evidenced by fluorescein angiography. The
use of high-frequency ultrasound (UBM) nicely
showed supraciliary effusion explaining the acute
onset of myopia [10–12].
Conclusion
Vogt-Koyanagi-Harada (VKH) disease is a primary
stromal choroiditis [13]. In contrast to other choro-
iditides, such as choroiditis caused by sarcoidosis
where the choroı¨d is an innocent host and where
choroidal lesions are the result of random involve-
ment by a systemic process, in VKH the islets of
stromal melanocytes are the primary target of the
inflammatory reaction. Therefore the initial inflam-
matory events such as the formation of stromal
Fig. 7 (a) ICGA OD after
three days of intravenous
infusion of
methylprednisolone:
hypofluorescent dark dots
are nearly completely
erased in the posterior pole.
(b) ICGA OD before
methyl prednisolone IV
therapy: in comparison to
Fig. 7a the hypofluorescent
dark dots are more
numerous and better
delineated in the posterior
pole
Fig. 8 Wide-angle ICGA OD: this wide-angle ICGA frame
clearly shows that the hypofluorescence is still present in the
periphery after three days of IV methylprednisolone therapy
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choroidal granlomata take place in the choroidal
stroma and the inflammatory reaction of adjacent
structures such as the retina or optic disc only occur
secondarily to the primary choroidal stromal events.
Until the introduction of indocyanine green angiog-
raphy (ICGA) the choroidal compartment could not
be explored in a sensitive manner and only secondary
inflammatory signs involving neighboring structures
were recorded in VKH disease. It has been shown
that ICGA is a sensitive method to detect the primary
stromal inflammatory events that often preceding
clinically detectable signs and it is obvious that ICGA
represents the method of choice to detect these early
events and is of great help to the clinician [5, 6].
Similarly in dubious cases when the suspected
diagnosis is sufficiently probable, lumbar puncture
should be performed in order to confirm the diagno-
sis. Together these diagnostic modalities allow the
clinician to make the diagnosis of VKH even when
all criteria are not present and they certainly represent
a significant improvement in diagnostic and follow-
up precision.
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